EVP R&D, Chief Medical Officer
Thu, Dec 5, 2024
Dec 5
9,221 shares @ $31.50
Decreased holdings by -13.40%
30th largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 17% above 200-day moving average